tiprankstipranks
Trending News
More News >
Cumberland Pharmaceuticals Inc (CPIX)
NASDAQ:CPIX
US Market

Cumberland Pharmaceuticals (CPIX) Income Statement

Compare
227 Followers

Cumberland Pharmaceuticals Income Statement

Last quarter (Q4 2025), Cumberland Pharmaceuticals's total revenue was $13.68M, an increase of 31.08% from the same quarter last year. In Q4, Cumberland Pharmaceuticals's net income was $-1.41M. See Cumberland Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 44.52M$ 37.87M$ 39.55M$ 42.01M$ 35.99M
Gross Profit
$ 37.85M$ 31.28M$ 33.49M$ 32.89M$ 27.17M
Operating Expenses
$ 40.65M$ 37.71M$ 43.04M$ 38.60M$ 34.85M
Depreciation and Amortization
$ 5.29M$ 6.04M$ 8.10M$ 5.33M$ 4.61M
EBITDA
$ 2.49M$ 182.42K$ 2.49M$ 332.92K$ -857.83K
Operating Income
$ -2.79M$ -6.43M$ -9.55M$ -5.70M$ -7.68M
Other Income/Expenses
$ -32.46K$ -33.98K$ 3.27M$ 123.74K$ 2.12M
Pretax Income
$ -2.82M$ -6.47M$ -6.28M$ -5.58M$ -5.56M
Net Income
$ -2.84M$ -6.48M$ -6.28M$ -5.57M$ -3.51M
Per Share Metrics
Basic EPS
$ -0.19$ -0.46$ -0.44$ -0.38$ -0.24
Diluted EPS
$ -0.19$ -0.46$ -0.44$ -0.38$ -0.24
Weighted Average Shares Outstanding
14.96M 14.06M 14.30M 14.56M 14.90M
Weighted Average Shares Outstanding (Diluted)
14.96M 14.06M 14.30M 14.56M 14.90M
Currency in USD

Cumberland Pharmaceuticals Earnings and Revenue History